Therefore, exosomal AQP1 can be used as a biomarker to detect renal I/R injury at the early onset and enable the monitoring of renal transplant patients and the prediction of post-transplant AKI caused by I/R. This evidence concerns the gene AQP1 and acute kidney injury.